Neuro-Degenerative Disease Clinical Trial
Official title:
Study of Cerebral Glucose Metabolism in Healthy Volunteers Using 18 F-FDG PET: Evaluation of the Effects of Aging, Comparative Evaluation of Neurodegenerative and Psychiatric Pathologies.
The aim of the study is to obtain information on cerebral glucose metabolism measured with the 18F-FDG PET technique in normal subjects without current or previous neurological or psychiatric pathologies in order to use the data obtained for voxel-based statistical analyzes for comparison with individual subjects ( patients with disease neurological or psychiatric) which will be evaluated with the same method to improve the specificity and diagnostic sensitivity of the FDG PET exam. The objective is to obtain a functional measure of brain glucose metabolism in every normal subject because this is a functional measure of brain activity. The subjects will represent different decades of age to have a wider range of comparison with patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05586750 -
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
|
Phase 4 | |
| Completed |
NCT04050800 -
Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety
|
Early Phase 1 | |
| Recruiting |
NCT04863859 -
Persons With Dementia and Their Extended Family Caregivers
|
||
| Recruiting |
NCT05655650 -
Identifying Biomarkers in Alzheimer's Disease
|
||
| Completed |
NCT04937127 -
Efficiency of E-learning and Role-playing for the Training of Nursing Home Caregivers in the Support of Agitation in Neurodegenerative Diseases
|
||
| Enrolling by invitation |
NCT03197363 -
Białystok PLUS - Polish Longitudinal University Study
|
||
| Enrolling by invitation |
NCT03322306 -
Establishment of Genetic Basis for Neurological Disease by Genetic Screening
|
||
| Completed |
NCT03439163 -
Large Sample PD Patients and Healthy Controls
|
N/A | |
| Withdrawn |
NCT05921929 -
First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)
|
Phase 1 | |
| Recruiting |
NCT05209698 -
Self-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health Outcomes
|
||
| Completed |
NCT04362228 -
The Effects of Whole-body Exercise to Improve Swallowing Function in Older Adults With Dementia
|
N/A | |
| Enrolling by invitation |
NCT05008094 -
The Epidemiology of Parkinson's Disease in Croatia and the Influence of Genetic Factors and Microbiota on the Progression and Treatment Outcomes of the Disease (GiOPARK)
|
||
| Completed |
NCT03279991 -
Neuromed- Integrated Health Life Platform and Biobank
|
||
| Active, not recruiting |
NCT04228653 -
Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05328492 -
Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis
|
N/A | |
| Not yet recruiting |
NCT06151600 -
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
|
||
| Recruiting |
NCT04880356 -
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
|
||
| Active, not recruiting |
NCT03609125 -
Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma
|
N/A | |
| Recruiting |
NCT03153670 -
3T MRI in Patients With Deep Brain Stimulation (DBS)
|
N/A | |
| Completed |
NCT03775538 -
Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study
|
Phase 1/Phase 2 |